Evidence map›Paper›PMID 33748877›Full record

ReviewCurrent urology reports2021

Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy.

Masatomo Kaneko, Dordaneh Sugano, Amir H Lebastchi, Vinay Duddalwar, Jamal Nabhani, Christopher Haiman, Inderbir S Gill, Giovanni E Cacciamani, Andre Luis Abreu

Abstract readReview
In one paragraph

Review in Current urology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Precision interventional radiology.Journal of interventional medicine · 2021
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masatomo KanekoUSC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Center for Image-Guided Surgery and Focal Therapy, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Dordaneh SuganoUSC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Center for Image-Guided Surgery and Focal Therapy, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Amir H LebastchiUSC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Center for Image-Guided Surgery and Focal Therapy, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Vinay DuddalwarDepartment of Radiology, Keck School of Medicine, University of Southern California, 1441 Eastlake Ave, Suite 7416, Los Angeles, CA, 90089, USA.
Jamal NabhaniUSC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Center for Image-Guided Surgery and Focal Therapy, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Christopher HaimanUSC Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Inderbir S GillUSC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Center for Image-Guided Surgery and Focal Therapy, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Giovanni E CacciamaniUSC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Center for Image-Guided Surgery and Focal Therapy, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Andre Luis AbreuUSC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Center for Image-Guided Surgery and Focal Therapy, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. andre.abreu@med.usc.edu.

Funding

Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsyR01CA205058 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GILL, INDERBIR, STERN, MARIANA C · 2016 to 2019
$2.1M
NCI NIH HHS R01 CA205058NIH (National Institutes of Health)/NCI (National Cancer Institute) Grant R01 CA205058-01
6 · The paper itself

Abstract

purpose of reviewThe goal of this study is to review recent findings and evaluate the utility of MRI transrectal ultrasound fusion biopsy (FBx) techniques and discuss future directions. RECENT

findingsFBx detects significantly higher rates of clinically significant prostate cancer (csPCa) than ultrasound-guided systematic prostate biopsy (SBx), particularly in repeat biopsy settings. FBx has also been shown to detect significantly lower rates of clinically insignificant prostate cancer. In addition, a dedicated prostate MRI can assist in more accurately predicting the Gleason score and provide further information regarding the index cancer location, prostate volume, and clinical stage. The ability to accurately evaluate specific lesions is vital to both focal therapy and active surveillance, for treatment selection, planning, and adequate follow-up. FBx has been demonstrated in multiple high-quality studies to have improved performance in diagnosis of csPCa compared to SBx. The combination of FBx with novel technologies including radiomics, prostate-specific membrane antigen positron emission tomography (PSMA PET), and high-resolution micro-ultrasound may have the potential to further enhance this performance.

Indexed as

HumansImage-Guided BiopsyMagnetic Resonance ImagingMagnetic Resonance Imaging, InterventionalMaleMultimodal ImagingNeoplasm GradingProstatic NeoplasmsUltrasonography, InterventionalFusion biopsyImage registrationMagnetic resonance imagingProstate cancerSystematic biopsyUltrasonography

Identifiers

PMID33748877
PMCPMC9827754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.